Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Köberle, Verena ^a   Pleli, Thomas ^a   Schmithals, Christian ^a   Augusto Alonso, Eduardo ^a   Haupenthal, Jörg ^a,b   Bönig, Halvard ^a   Peveling Oberhag, Jan ^a   Biondi, Ricardo M ^a   Zeuzem, Stefan ^a   Kronenberger, Bernd ^a   Waidmann, Oliver ^a   Piiper, Albrecht ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 1; MICRORNA 122; MICRORNA 142 3P; MICRORNA 16; MICRORNA 21; RIBONUCLEASE A; RIBONUCLEASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ENCAPSULATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HEMOLYSIS; HUMAN; HUMAN CELL; INCUBATION TIME; MEMBRANE VESICLE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA DEGRADATION; RNA STABILITY;

ENZYME INHIBITORS; ERYTHROCYTES; HEALTHY VOLUNTEERS; HUMANS; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE, PANCREATIC; RNA STABILITY; SERUM; TUMOR MARKERS, BIOLOGICAL;

EID: 84884471107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075184     Document Type: Article

References (30)

1. Du T, Zamore PD, (2005) microPrimer: the biogenesis and function of microRNA. Development 132: 4645-4652. doi:10.1242/dev.02070. PubMed: 16224044.
2. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591. doi:10.1016/j.cell.2009.02.005. PubMed: 19239879.
3. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675. doi:10.1111/j.1365-2141.2008.07077.x. PubMed: 18318758.
4. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006. doi:10.1038/cr.2008.282. PubMed: 18766170.
5. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518. doi:10.1073/pnas.0804549105. PubMed: 18663219.
6. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008. doi:10.1073/pnas.1019055108. PubMed: 21383194.
7. Turchinovich A, Weiz L, Langheinz A, Burwinkel B, (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39: 7223-7233. doi:10.1093/nar/gkr254. PubMed: 21609964.
8. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT, (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13: 423-433. doi:10.1038/ncb2210. PubMed: 21423178.
9. Li L, Zhu D, Huang L, Zhang J, Bian Z, et al. (2012) Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLOS ONE 7: e46957. doi:10.1371/journal.pone.0046957. PubMed: 23077538.
10. Gallo A, Tandon M, Alevizos I, Illei GG, (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLOS ONE 7: e30679. doi:10.1371/journal.pone.0030679. PubMed: 22427800.
11. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659. doi:10.1038/ncb1596. PubMed: 17486113.
12. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739. doi:10.1016/S0960-9822(02)00809-6. PubMed: 12007417.
13. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, et al. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106: 4402-4407. doi:10.1073/pnas.0813371106. PubMed: 19246379.
14. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, et al. (2009) Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55: 1977-1983. doi:10.1373/clinchem.2009.131797. PubMed: 19745058.
15. Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, et al. (2011) Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 106: 1663-1669. doi:10.1038/ajg.2011.161. PubMed: 21606975.
16. Köberle V, Waidmann O, Kronenberger B, Andrei A, Susser S, et al. (2013) Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy. J Viral Hepat 20: 530-535. doi:10.1111/jvh.12075. PubMed: 23808991.
17. Waidmann O, Bihrer V, Pleli T, Farnik H, Berger A, et al. (2012) Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat 19: e58-e65. doi:10.1111/j.1365-2893.2011.01536.x. PubMed: 22239527.
18. Köberle V, Kronenberger B, Pleli T, Trojan J, Imelmann E, et al. (2013) Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Eur J Cancer. Available at: http://dx.doi.org/10.1016/j.ejca.2013.06.002.
19. Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, et al. (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56: 1946-1957. doi:10.1002/hep.25873. PubMed: 22684891.
20. Welker MW, Reichert D, Susser S, Sarrazin C, Martinez Y, et al. (2012) Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity. PLOS ONE 7: e30796. doi:10.1371/journal.pone.0030796. PubMed: 22355327.
21. Weickmann JL, Glitz DG, (1982) Human ribonucleases. Quantitation of pancreatic-like enzymes in serum, urine, and organ preparations. J Biol Chem 257: 8705-8710. PubMed: 6284742.
22. Morita T, Niwata Y, Ohgi K, Ogawa M, Irie M, (1986) Distribution of two urinary ribonuclease-like enzymes in human organs and body fluids. J Biochem 99: 17-25. PubMed: 3514589.
23. Sorrentino S, De Prisco R, Libonati M, (1989) Human seminal ribonuclease. Immunological quantitation of cross-reactive enzymes in serum, urine and seminal plasma. Biochim Biophys Acta 998: 97-101. doi:10.1016/0167-4838(89)90125-8. PubMed: 2790056.
24. Nadano D, Yasuda T, Takeshita H, Kishi K, (1995) Ribonuclease inhibitors in human blood: comparative studies on the inhibitors detected in erythrocytes, platelets, mononuclear leukocytes and granulocytes. Int J Biochem Cell Biol 27: 971-979. doi:10.1016/1357-2725(95)00063-U. PubMed: 7584633.
25. Wang K, Zhang S, Weber J, Baxter D, Galas DJ, (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38: 7248-7259. doi:10.1093/nar/gkq601. PubMed: 20615901.
26. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A, (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840. doi:10.1373/clinchem.2010.157198. PubMed: 21487102.
27. Haupenthal J, Baehr C, Kiermayer S, Zeuzem S, Piiper A, (2006) Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum. Biochem Pharmacol 71: 702-710. doi:10.1016/j.bcp.2005.11.015. PubMed: 16376306.
28. Haupenthal J, Baehr C, Zeuzem S, Piiper A, (2007) RNAse A-like enzymes in serum inhibit the anti-neoplastic activity of siRNA targeting polo-like kinase 1. Int J Cancer 121: 206-210. doi:10.1002/ijc.22665. PubMed: 17351902.
29. Turner JJ, Jones SW, Moschos SA, Lindsay MA, Gait MJ, (2007) MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity. Mol Biosyst 3: 43-50. doi:10.1039/b611612d. PubMed: 17216055.
30. Paris C, Moreau V, Deglane G, Karim L, Couturier B, et al. (2012) Conjugating phosphospermines to siRNAs for improved stability in serum, intracellular delivery and RNAi-Mediated gene silencing. Mol Pharm 9: 3464-3475. doi:10.1021/mp300278b. PubMed: 23148419.